Journal of Microencapsulation,
Год журнала:
2024,
Номер
unknown, С. 1 - 12
Опубликована: Дек. 23, 2024
Plant-derived
extracellular
vesicles
(EVs)
are
natural
nanovesicles
for
drug
delivery.
This
study
isolated
and
characterised
EVs
from
medicinal
plants
as
delivery
vehicles.
Journal of Functional Biomaterials,
Год журнала:
2025,
Номер
16(1), С. 24 - 24
Опубликована: Янв. 14, 2025
Autoimmune
diseases
present
complex
therapeutic
challenges
due
to
their
chronic
nature,
systemic
impact,
and
requirement
for
precise
immunomodulation
avoid
adverse
side
effects.
Recent
advancements
in
biodegradable
stimuli-responsive
nanomaterials
have
opened
new
avenues
targeted
drug
delivery
systems
capable
of
addressing
these
challenges.
This
review
provides
a
comprehensive
analysis
state-of-the-art
nanocarriers
such
as
polymeric
nanoparticles,
liposomes,
hydrogels
engineered
autoimmune
therapies.
These
are
designed
degrade
safely
the
body
while
releasing
agents
response
specific
stimuli,
including
pH,
temperature,
redox
conditions,
enzymatic
activity.
By
achieving
localized
controlled
release
anti-inflammatory
immunosuppressive
agents,
minimize
toxicity
enhance
efficacy.
We
discuss
underlying
mechanisms
nanomaterials,
recent
applications
treating
rheumatoid
arthritis,
multiple
sclerosis,
inflammatory
bowel
disease,
design
considerations
essential
clinical
translation.
Additionally,
we
address
current
challenges,
biocompatibility,
scalability,
regulatory
hurdles,
well
future
directions
integrating
advanced
nanotechnology
with
personalized
medicine
treatment.
highlights
transformative
potential
presenting
them
promising
strategy
advance
precision
improve
patient
outcomes
disease
management.
This
review
explores
the
evolution
of
lipid-based
nanoparticles
(LBNPs)
for
drug
delivery
(DD).
Herein,
LBNPs
are
classified
into
liposomes
and
cell
membrane-based
(CMNPs),
each
with
unique
advantages
challenges.
Conventional
possess
drawbacks
such
as
poor
targeting,
quick
clearance,
limited
biocompatibility.
One
possible
alternatives
to
overcome
these
challenges
is
surface
modification
(NPs)
materials
polyethylene
glycol
(PEG),
aptamers,
antibody
fragments,
peptides,
CD44,
hyaluronic
acid,
folic
palmitic
lactoferrin.
Thus,
main
focus
this
will
be
on
different
modifications
that
enable
have
beneficial
properties
DD,
enhancing
mass
transport
properties,
immune
evasion,
improved
stability,
targeting.
Moreover,
various
CMNPs
explored
used
DD
derived
from
cells
red
blood
(RBCs),
platelets,
leukocytes,
cancer
cells,
stem
highlighting
their
natural
(e.g.,
biocompatibility
ability
evade
system).
discussion
extends
biomimicking
hybrid
NPs
accomplished
through
coating
synthetic
(mainly
polymeric)
membranes.
aims
provide
a
comprehensive
resource
researchers
recent
advances
in
field
CMNPs.
Overall,
provides
valuable
insights
dynamic
systems.
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
178, С. 117248 - 117248
Опубликована: Авг. 3, 2024
Exosome-nanoparticle
hybrid
nanoplatforms,
can
be
prepared
by
combining
exosomes
with
different
types
of
nanoparticles.
The
main
purpose
nanoparticles
is
to
overcome
the
limitations
using
each
them
as
drug
delivery
systems.
Using
for
has
some
limitations,
such
high
immunogenicity,
poor
cellular
uptake,
low
biocompatibility,
cytotoxicity,
stability,
and
rapid
clearance
immune
cells.
However,
systems
also
its
own
drawbacks,
encapsulation
efficiency,
production
yield,
inability
load
large
molecules.
These
addressed
utilizing
nanoplatforms.
Additionally,
use
allows
targeted
within
system.
Exosome-inorganic/organic
may
used
both
therapy
diagnosis
in
future.
This
lead
development
personalized
medicine
there
are
a
few
challenges
associated
this.
Surface
modifications,
adding
functional
groups,
surface
charge
adjustments,
preparing
desired
size
crucial
possibility
exosome-nanoparticle
hybrids.
Additional
successful
implementation
platforms
medical
treatments
diagnostics
include
scaling
up
manufacturing
process
ensuring
consistent
quality
reproducibility
across
various
batches.
review
focuses
on
discusses
preparation
loading
methods
these
Furthermore,
potential
applications
nanocarriers
drug/gene
delivery,
disease
treatment
diagnosis,
cell/tissue
imaging
explained.
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Янв. 19, 2024
Mycobacterium
tuberculosis
(
M.tb
)
effectively
manipulates
the
host
processes
to
establish
deadly
respiratory
disease,
Tuberculosis
(TB).
has
developed
key
mechanisms
disrupt
cell
health
combat
immune
responses
and
replicate
efficaciously.
antigens
such
as
ESAT-6,
19kDa
lipoprotein,
Hip1,
Hsp70
destroy
integrity
of
organelles
(Mitochondria,
Endoplasmic
Reticulum,
Nucleus,
Phagosomes)
or
delay
innate/adaptive
responses.
This
is
followed
by
induction
cellular
stress
in
host.
Such
cells
can
either
undergo
various
death
apoptosis
necrosis,
mount
effective
clear
invading
pathogen.
Further,
infection
progression,
secretes
extracellular
vesicles
exosomes
initiate
signaling.
The
contain
well
cell-derived
peptides
that
act
a
double-edged
sword
signaling
event.
host-symbiont
microbiota
produces
metabolites
are
beneficial
for
maintaining
healthy
tissue
microenvironment.
In
juxtaposition
above-mentioned
mechanisms,
dysregulates
gut
microbiome
support
its
replication
dissemination
process.
interconnected
Immunometabolism,
Cellular
stress,
Host
Microbiome,
Extracellular
less
explored
realm
exploration
novel
Host-directed
therapies
TB.
Therefore,
this
review
highlights
intertwined
control
survival
showcases
important
factors
be
targeted
designing
efficacious
therapy.
Extracellular Vesicle,
Год журнала:
2024,
Номер
3, С. 100044 - 100044
Опубликована: Май 13, 2024
Spinal
cord
injury
(SCI)
is
the
damage
to
spinal
causing
paralysis
below
site
compromised
patient
life
quality.
Exosomes
are
nanosized
vesicles
released
during
physiological
or
pathological
processes.
They
present
a
promising
avenue
for
therapeutic
drug
delivery
due
their
tissue
specificity
and
biocompatibility,
offering
enhanced
efficacy
with
reduced
accumulation-based
toxicity.
In
SCI,
exosomes
target
inflammation,
apoptosis,
microglial
polarization,
autophagy,
contributing
interventions.
This
article
comprehensively
explores
pathophysiology
of
diverse
exosome
synthesis
processes,
limitations
challenges
overcome,
potential
from
various
cellular
sources
in
SCI
treatment.
Cancer Cell International,
Год журнала:
2025,
Номер
25(1)
Опубликована: Апрель 15, 2025
Abstract
Brain
cancer
remains
a
significant
challenge
in
the
field
of
oncology,
primarily
because
its
aggressive
nature
and
limited
treatment
options
available.
Conventional
therapies
often
fall
short
effectively
targeting
tumor
cells,
while
sparing
healthy
brain
tissue
from
collateral
damage.
However,
exosomes
are
now
recognized
as
promising
nanocarriers
for
targeted
drug
delivery.
These
naturally
occurring
extracellular
vesicles
can
cross
blood–brain
barrier
selectively
interact
with
cells.
Utilizing
delivery
vehicles
offers
novel
approach
potential
therapy.
By
encapsulating
therapeutic
agents
within
exosomes,
drugs
be
specifically
to
maximizing
their
impact
whilst
minimizing
damage
tissue.
Furthermore,
modified
display
molecules
that
recognize
bind
further
enhancing
precision
efficacy.
While
exosome-based
show
potential,
scalability,
purification,
clinical
application
challenges
remain.
The
scalability
exosome
production,
modification
techniques
hurdle
must
overcome
translation.
Additionally,
intricate
interactions
between
microenvironment
necessitate
research
optimize
outcomes.
review
explores
applications
future
perspectives
advancing
treatment.